These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 33016237

  • 1. Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus.
    Jiang Y, Liu L, Manning M, Bonahoom M, Lotvola A, Yang Z, Yang ZQ.
    J Biomol Struct Dyn; 2022 Feb; 40(3):1331-1346. PubMed ID: 33016237
    [Abstract] [Full Text] [Related]

  • 2. Computational investigation of potent inhibitors against SARS-CoV-2 2'-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations.
    Shi L, Wen Z, Song Y, Wang J, Yu D.
    J Mol Graph Model; 2022 Dec; 117():108306. PubMed ID: 36063745
    [Abstract] [Full Text] [Related]

  • 3. In silico validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.
    Maurya AK, Mishra N.
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [Abstract] [Full Text] [Related]

  • 4. Integrated molecular and quantum mechanical approach to identify novel potent natural bioactive compound against 2'-O-methyltransferase (nsp16) of SARS-CoV-2.
    Thomas J, Kumar S, Satija J.
    J Biomol Struct Dyn; 2024 Nov; 42(4):1999-2012. PubMed ID: 37129206
    [Abstract] [Full Text] [Related]

  • 5. Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16.
    Wu K, Guo Y, Xu T, Huang W, Guo D, Cao L, Lei J.
    Molecules; 2024 May 15; 29(10):. PubMed ID: 38792173
    [Abstract] [Full Text] [Related]

  • 6. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
    Aldahham BJM, Al-Khafaji K, Saleh MY, Abdelhakem AM, Alanazi AM, Islam MA.
    J Biomol Struct Dyn; 2022 Jun 15; 40(9):3899-3906. PubMed ID: 33252031
    [Abstract] [Full Text] [Related]

  • 7. Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.
    Encinar JA, Menendez JA.
    Viruses; 2020 May 10; 12(5):. PubMed ID: 32397643
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Structural and functional insights into the 2'-O-methyltransferase of SARS-CoV-2.
    Deng J, Gong F, Li Y, Tan X, Liu X, Yang S, Chen X, Wang H, Liu Q, Shen C, Zhou L, Chen Y.
    Virol Sin; 2024 Aug 10; 39(4):619-631. PubMed ID: 38969340
    [Abstract] [Full Text] [Related]

  • 10. Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase.
    Khan RJ, Jha RK, Amera GM, Jain M, Singh E, Pathak A, Singh RP, Muthukumaran J, Singh AK.
    J Biomol Struct Dyn; 2021 May 10; 39(8):2679-2692. PubMed ID: 32266873
    [Abstract] [Full Text] [Related]

  • 11. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
    Chen Y, Su C, Ke M, Jin X, Xu L, Zhang Z, Wu A, Sun Y, Yang Z, Tien P, Ahola T, Liang Y, Liu X, Guo D.
    PLoS Pathog; 2011 Oct 10; 7(10):e1002294. PubMed ID: 22022266
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches.
    El Hassab MA, Ibrahim TM, Al-Rashood ST, Alharbi A, Eskandrani RO, Eldehna WM.
    J Enzyme Inhib Med Chem; 2021 Dec 10; 36(1):727-736. PubMed ID: 33685335
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10.
    Zhao H, Liu J, He L, Zhang L, Yu R, Kang C.
    Biochem Biophys Res Commun; 2022 Oct 20; 626():114-120. PubMed ID: 35988295
    [Abstract] [Full Text] [Related]

  • 19. Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study.
    Vijayan V, Pant P, Vikram N, Kaur P, Singh TP, Sharma S, Sharma P.
    J Biomol Struct Dyn; 2021 Oct 20; 39(17):6713-6727. PubMed ID: 32741322
    [Abstract] [Full Text] [Related]

  • 20. Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2'-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs.
    Eissa IH, Alesawy MS, Saleh AM, Elkaeed EB, Alsfouk BA, El-Attar AMM, Metwaly AM.
    Molecules; 2022 Mar 31; 27(7):. PubMed ID: 35408684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.